JP2020523029A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523029A5 JP2020523029A5 JP2019569397A JP2019569397A JP2020523029A5 JP 2020523029 A5 JP2020523029 A5 JP 2020523029A5 JP 2019569397 A JP2019569397 A JP 2019569397A JP 2019569397 A JP2019569397 A JP 2019569397A JP 2020523029 A5 JP2020523029 A5 JP 2020523029A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- cancer
- hue71
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520382P | 2017-06-15 | 2017-06-15 | |
| US62/520,382 | 2017-06-15 | ||
| PCT/US2018/037645 WO2018232188A1 (en) | 2017-06-15 | 2018-06-14 | Anti-l1-cam antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523029A JP2020523029A (ja) | 2020-08-06 |
| JP2020523029A5 true JP2020523029A5 (https=) | 2021-07-26 |
| JP7353187B2 JP7353187B2 (ja) | 2023-10-05 |
Family
ID=64660699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569397A Active JP7353187B2 (ja) | 2017-06-15 | 2018-06-14 | 抗ｌ１－ｃａｍ抗体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11597764B2 (https=) |
| EP (1) | EP3638299A4 (https=) |
| JP (1) | JP7353187B2 (https=) |
| CN (2) | CN111093693B (https=) |
| CA (1) | CA3067351A1 (https=) |
| IL (1) | IL271398A (https=) |
| WO (1) | WO2018232188A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2904969C (en) | 2013-03-13 | 2025-06-17 | Imaginab, Inc. | DIFFERENTIATION CLUSTER ANTIGEN-BINDING GENETIC CONSTRUCTIONS 8 |
| WO2017027325A1 (en) | 2015-08-07 | 2017-02-16 | Imaginab, Inc. | Antigen binding constructs to target molecules |
| JP7353187B2 (ja) * | 2017-06-15 | 2023-10-05 | メモリアル スローン－ケタリング キャンサー センター | 抗ｌ１－ｃａｍ抗体およびその使用 |
| WO2020003210A1 (en) | 2018-06-29 | 2020-01-02 | Kangwon National University University-Industry Cooperation Foundation | Anti-l1cam antibodies and uses thereof |
| EP3938400B1 (en) | 2019-03-11 | 2025-07-30 | Memorial Sloan Kettering Cancer Center | Cd22 antibodies and methods of using the same |
| WO2021231720A1 (en) * | 2020-05-15 | 2021-11-18 | Alexion Pharmaceuticals, Inc. | Method of using extracellular vesicles to detect complement activation, and uses thereof to assess and/or monitor treatment of a complement-mediated disease |
| CN114558122B (zh) * | 2022-04-27 | 2023-02-21 | 北京肿瘤医院(北京大学肿瘤医院) | 放射核素标记的过氧化氢酶及其应用 |
| TW202421652A (zh) * | 2022-09-21 | 2024-06-01 | 瑞士商艾爾瑟拉股份有限公司 | 結合至l1cam之新穎結合分子 |
| IL320220A (en) | 2022-11-09 | 2025-06-01 | Cis Biopharma Ag | Antibodies against L1-CAM and their uses for diagnostic and therapeutic applications |
| WO2025238187A1 (en) | 2024-05-15 | 2025-11-20 | Cis Biopharma Ag | Immunoconjugates targeting l1-cam |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107045A (en) * | 1994-06-30 | 2000-08-22 | Oklahoma Medical Research Foundation | Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| US6972323B1 (en) | 1997-04-01 | 2005-12-06 | Sankyo Company, Limited | Anti-Fas antibodies |
| WO2007114550A1 (en) * | 2006-04-03 | 2007-10-11 | Korea Research Institute Of Bioscience And Biotechnology | A novel monoclonal antibody specific to the l1cam, a hybridoma producing the same and a method producing the same |
| AR061170A1 (es) * | 2006-06-02 | 2008-08-06 | Aveo Pharmaceuticals Inc | Proteinas que se unen con el factor de crecimiento de hepatocitos (hgf) |
| EP2054083B1 (en) * | 2006-08-23 | 2013-11-27 | Korea Research Institute of Bioscience and Biotechnology | A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| AU2008201871A1 (en) * | 2008-04-16 | 2009-11-26 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Inhibition of angiogenesis and tumor metastasis |
| KR101501736B1 (ko) * | 2008-12-05 | 2015-03-12 | 한국생명공학연구원 | 인간 및 마우스에서 발현하는 ｌ1ｃａｍ에 특이적으로 결합하는 재조합 단일클론항체 및 그 이용 |
| CN102666585B (zh) * | 2009-11-24 | 2015-02-18 | 阿莱斯亚生物疗法股份有限公司 | 抗簇蛋白抗体和抗原结合片段及其减小肿瘤体积的用途 |
| US20130236467A1 (en) | 2010-11-24 | 2013-09-12 | Jeremy Griggs | Multispecific antigen binding proteins targeting hgf |
| SG10201602394QA (en) * | 2011-03-29 | 2016-05-30 | Roche Glycart Ag | Antibody FC Variants |
| US9764038B2 (en) * | 2011-12-23 | 2017-09-19 | Innate Pharma | Enzymatic conjugation of antibodies |
| WO2014077648A1 (ko) * | 2012-11-16 | 2014-05-22 | 강원대학교산학협력단 | 인간 및 마우스 ｌ１ｃａｍ 단백질에 특이적으로 결합하는 항체 및 이의 용도 |
| JP6584012B2 (ja) * | 2013-10-06 | 2019-10-02 | アメリカ合衆国 | 改変シュードモナス外毒素ａ |
| JP7353187B2 (ja) * | 2017-06-15 | 2023-10-05 | メモリアル スローン－ケタリング キャンサー センター | 抗ｌ１－ｃａｍ抗体およびその使用 |
-
2018
- 2018-06-14 JP JP2019569397A patent/JP7353187B2/ja active Active
- 2018-06-14 CN CN201880052266.7A patent/CN111093693B/zh active Active
- 2018-06-14 EP EP18818419.6A patent/EP3638299A4/en active Pending
- 2018-06-14 CA CA3067351A patent/CA3067351A1/en active Pending
- 2018-06-14 US US16/622,274 patent/US11597764B2/en active Active
- 2018-06-14 WO PCT/US2018/037645 patent/WO2018232188A1/en not_active Ceased
- 2018-06-14 CN CN202411020658.9A patent/CN119161477A/zh active Pending
-
2019
- 2019-12-12 IL IL271398A patent/IL271398A/en unknown
-
2023
- 2023-03-06 US US18/179,159 patent/US12486323B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020523029A5 (https=) | ||
| Wei et al. | Current landscape and future directions of bispecific antibodies in cancer immunotherapy | |
| Goebeler et al. | Bispecific and multispecific antibodies in oncology: opportunities and challenges | |
| Paul et al. | Cancer therapy with antibodies | |
| Herrera et al. | Bispecific antibodies: advancing precision oncology | |
| Barzaman et al. | Breast cancer immunotherapy: Current and novel approaches | |
| JP2021531764A5 (https=) | ||
| IL273484B1 (en) | A33 antibody compositions and methods of using the same in radioimmunotherapy | |
| JP2020103301A5 (https=) | ||
| Chandramohan et al. | Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy | |
| JP2020534017A5 (https=) | ||
| Lutterbuese et al. | Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA | |
| JP2020534250A5 (https=) | ||
| JP2020501531A5 (https=) | ||
| JP2021517816A5 (https=) | ||
| JP2021520208A5 (https=) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| JP2020507571A5 (https=) | ||
| JP2020512281A5 (https=) | ||
| JP2015529641A5 (https=) | ||
| US20240197931A1 (en) | Radioimmunotherapy directed to ccr8 for depletion of tumor infiltrating regulatory t cells | |
| JP2005538701A5 (https=) | ||
| Lan et al. | Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview | |
| JP2023520392A (ja) | 間葉系幹細胞由来癌細胞および間葉系幹細胞関連疾患を標的とするイムノセラノスティック剤（ｉｍｍｕｎｏｔｈｅｒａｎｏｓｔｉｃ ａｇｅｎｔ） | |
| CN104211814A (zh) | 用于消耗靶膜蛋白的组合物 |